申请人:ENVOY THERAPEUTICS INC
公开号:WO2014014951A1
公开(公告)日:2014-01-23
The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
本发明提供了式(I)的5-HT3受体拮抗剂,用于治疗通过抑制5-HT3受体可治疗的疾病,如呕吐、疼痛、药物成瘾、神经退行性和精神障碍以及胃肠道疾病。还提供了含有这类化合物的药物组合物和制备这类化合物的方法。